RECRUITING

Adjunctive Bright Light Therapy for Opioid Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Investigators propose to conduct a pilot single-blind, parallel arm, randomized placebo-controlled trial evaluating the feasibility, acceptability, and preliminary efficacy of bright light therapy on reward system functioning among patients undergoing medication-assisted treatment for opioid use disorder.

Official Title

Adjunctive Wearable Bright Light Therapy for Patients With Opioid Use Disorder: A Pilot Study

Quick Facts

Study Start:2022-10-23
Study Completion:2025-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05459922

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * age between 18 and 65
  2. * ability to speak, write, and read in English
  3. * past 2 weeks of insomnia as evidenced by Insomnia Severity Index (ISI) total score of ≥10
  4. * enrolled in outpatient medication-assisted treatment for OUD (i.e., either methadone or buprenorphine treatment)
  5. * been in medication-assisted treatment for at least 3 months
  6. * at least one month of stable methadone or buprenorphine dose
  7. * have a smartphone
  1. * lifetime history of bipolar disorder or mania
  2. * current narcolepsy, sleep paralysis, or restless leg syndrome as assessed by medical history
  3. * history of seizure disorders/epilepsy
  4. * the STOP-Bang score for obstructive sleep apnea ≥ 5
  5. * retinal pathology, history of eye surgery or taking photosensitizing medications (e.g., lithium, L-tryptophan)
  6. * current regular use of melatonin
  7. * have circumstances that would interfere with study participation (e.g., impending jail sentence)
  8. * previous experience with bright light therapy
  9. * working a night shift or traveling outside the Arizona time zone in the past month
  10. * pregnant, trying to get pregnant, or breastfeeding
  11. * currently wearing prescription glasses with blue-light protection

Contacts and Locations

Study Contact

Chung Jung Mun, Ph.D.
CONTACT
602-496-2992
ChungJung.Mun@asu.edu
Nina Winsick, M.S.
CONTACT
602-496-0665
nmwinsic@asu.edu

Principal Investigator

Chung Jung Mun, Ph.D.
PRINCIPAL_INVESTIGATOR
Arizona State University

Study Locations (Sites)

Arizona State University
Phoenix, Arizona, 85004
United States

Collaborators and Investigators

Sponsor: Arizona State University

  • Chung Jung Mun, Ph.D., PRINCIPAL_INVESTIGATOR, Arizona State University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-10-23
Study Completion Date2025-05-31

Study Record Updates

Study Start Date2022-10-23
Study Completion Date2025-05-31

Terms related to this study

Keywords Provided by Researchers

  • opioid use disorder
  • bright light therapy
  • reward function
  • methadone

Additional Relevant MeSH Terms

  • Opioid Use Disorder
  • Sleep Disturbance